Brazil’s ANVISA voted on January 28, 2026 to approve five new cannabis resolutions–RDC 1,011 through RDC 1,015–marking the most significant regulatory shift in the country’s medical cannabis market since 2019. Here’s what each resolution means for producers and operators.
Read More